AstraZeneca Tops BMI's Inaugural Pharmaceutical Manufacturing Efficiency Index

Compared with a selection of other drugmakers, AstraZeneca spends the smallest proportion of total sales on manufacturing, according to BMI's Pharmaceutical Manufacturing Efficiency Index (PMEI). For every US$1 the Anglo-Swedish firm spent on 'cost of goods sold' in 2009, it generated US$5.87 in revenue, giving it a score of 5.87 on our index

To read the full article, please choose one of the following options: